Literature DB >> 11161591

Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?

E G Stopa1, T M Berzin, S Kim, P Song, V Kuo-LeBlanc, M Rodriguez-Wolf, A Baird, C E Johanson.   

Abstract

The choroid plexus plays a key role in supporting neuronal function by secreting cerebrospinal fluid (CSF) and may be involved in the regulation of various soluble factors. Because the choroid plexus is involved in growth factor secretion as well as CSF dynamics, it is important to understand how growth factors in CSF interact with the brain parenchyma as well as with cells in direct contact with the flowing CSF, i.e., choroid plexus and arachnoid villi. While the existence of growth factors in the choroid plexus has been documented in several animal models, the presence and distribution of growth factors in the human choroid plexus has not been extensively examined. This study describes the general distribution and possible functions of a number of key proteins in the human choroid plexus and arachnoid villi, including basic fibroblast growth factor, FGF receptor, and vascular endothelial growth factor. FGF and VEGF could both be readily demonstrated in choroid plexus epithelial cells. The presence of FGF and VEGF within the choroid plexus was also confirmed by ELISA analysis. Since Alzheimer's disease (AD) is known to be associated with a number of growth factor abnormalities, we examined the choroid plexus and arachnoid villi from AD patients. Immunohistochemical studies revealed the presence of FGF and VEGF within the AD choroid plexus and an increased density of FGFr in both the choroid plexus and the arachnoid villi of AD patients. No qualitative changes in the distribution of FGF and VEGF were observed in the AD choroid plexus. The appearance of FGFr in AD arachnoid was associated with robust amyloid and vimentin immunoreactivity. These findings confirm the presence of FGF and VEGF within the normal and AD choroid plexus and suggest that the alteration of growth factors and their receptors may contribute to the pathogenesis of the hydrocephalus ex vacuo that is characteristically seen in AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161591     DOI: 10.1006/exnr.2000.7545

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  32 in total

1.  Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid.

Authors:  Ana Maria Gonzalez; Wendy Leadbeater; Sonia Podvin; Alexandra Borboa; Michael Burg; Ritsuko Sawada; James Rayner; Karen Sims; Tetsuya Terasaki; Conrad Johanson; Edward Stopa; Brian Eliceiri; Andrew Baird
Journal:  Brain Res       Date:  2010-08-21       Impact factor: 3.252

2.  Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. II. In vitro arachnoid outflow model.

Authors:  David W Holman; Vartan Kurtcuoglu; Deborah M Grzybowski
Journal:  J R Soc Interface       Date:  2010-03-24       Impact factor: 4.118

3.  Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. I. Computational model.

Authors:  Sumeet Gupta; Michaela Soellinger; Deborah M Grzybowski; Peter Boesiger; John Biddiscombe; Dimos Poulikakos; Vartan Kurtcuoglu
Journal:  J R Soc Interface       Date:  2010-03-17       Impact factor: 4.118

4.  VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus.

Authors:  Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Mark G Luciano
Journal:  J Neurol Sci       Date:  2010-09-15       Impact factor: 3.181

Review 5.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

6.  Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Brian R Ott; Ronald A Cohen; Assawin Gongvatana; Ozioma C Okonkwo; Conrad E Johanson; Edward G Stopa; John E Donahue; Gerald D Silverberg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Fractones: extracellular matrix niche controlling stem cell fate and growth factor activity in the brain in health and disease.

Authors:  Frederic Mercier
Journal:  Cell Mol Life Sci       Date:  2016-07-30       Impact factor: 9.261

8.  Co-localization and regulation of basic fibroblast growth factor and arginine vasopressin in neuroendocrine cells of the rat and human brain.

Authors:  Ana M Gonzalez; William M Taylor; Conrad E Johanson; Joan C King; Wendy E Leadbeater; Edward G Stopa; Andrew Baird
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

9.  Potential of choroid plexus epithelial cell grafts for neuroprotection in Huntington's disease: what remains before considering clinical trials.

Authors:  Dwaine F Emerich; Cesario V Borlongan
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

10.  Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation.

Authors:  Marta Bolos; Desireé Antequera; Jesús Aldudo; Henrike Kristen; María Jesús Bullido; Eva Carro
Journal:  Cell Mol Life Sci       Date:  2013-12-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.